Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Croce

Showing results (571-580 of 579) with videos related to

Pageof 58
Sort By:
You have reached the last page of results.This site can display upto 579 results.
Oncogene|November 19, 2013
Protumorigenic effects of mir-145 loss in malignant pleural mesotheliomaM Cioce, F Ganci, V Canu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2003
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangementsT Rozovskaia, O Ravid-Amir, S Tillib, et al.
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Oncogene|August 8, 2017
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse modelL D'Abundo, E Callegari, A Bresin, et al.
Leukemia|April 16, 2014
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemiaA Veronese, F Pepe, J Chiacchia, et al.
Leukemia|June 10, 2015
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiaA M Dorrance, P Neviani, G J Ferenchak, et al.
Blood Cancer Journal|November 11, 2014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specifiedM A Laginestra, P P Piccaluga, F Fuligni, et al.
Leukemia|February 8, 2014
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibitionM R Sapienza, F Fuligni, C Agostinelli, et al.
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.
Pageof 58

Showing results (571-580 of 579) with videos related to

Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 579 results.
Oncogene|November 19, 2013
Protumorigenic effects of mir-145 loss in malignant pleural mesotheliomaM Cioce, F Ganci, V Canu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2003
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangementsT Rozovskaia, O Ravid-Amir, S Tillib, et al.
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Oncogene|August 8, 2017
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse modelL D'Abundo, E Callegari, A Bresin, et al.
Leukemia|April 16, 2014
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemiaA Veronese, F Pepe, J Chiacchia, et al.
Leukemia|June 10, 2015
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiaA M Dorrance, P Neviani, G J Ferenchak, et al.
Blood Cancer Journal|November 11, 2014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specifiedM A Laginestra, P P Piccaluga, F Fuligni, et al.
Leukemia|February 8, 2014
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibitionM R Sapienza, F Fuligni, C Agostinelli, et al.
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.
Pageof 58